Form 4: 10x Genomics CFO Adam Taich Reports Acquisition of Shares Through Restricted Stock Units

Adam Taich, CFO of 10x Genomics, reports the acquisition of Class A Common Stock through restricted stock units (RSUs) on October 23, 2024 and March 17, 2025.

Summary

• Adam Taich, the Chief Financial Officer of 10x Genomics, filed a Form 4 detailing changes in beneficial ownership.
• On October 23, 2024, Taich acquired 201,704 shares of Class A Common Stock through restricted stock units (RSUs) at a price of $0.
• These RSUs vest in installments, with 1/4th vesting on August 21, 2024, and 1/16th vesting quarterly thereafter for three years, contingent upon continued service.
• On March 17, 2025, Taich acquired an additional 133,928 shares of Class A Common Stock through RSUs at a price of $0.
• These RSUs vest quarterly from February 21, 2025, with 1/12th vesting each quarter, contingent upon continued service.
• Following these transactions, Taich beneficially owns 335,632 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by the CFO is generally a good sign, indicating confidence in the company. However, it's a routine filing and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of shares by the CFO demonstrates confidence in the company's future.
• The vesting schedule of the RSUs incentivizes long-term commitment from the CFO.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the RSUs suggest an expectation of continued service by the CFO.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's acquisition of shares, which is a common practice for aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the CFO's acquisition of shares as a positive signal.
• Employees may see it as a sign of stability and confidence in the company's leadership.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Class A Common Stock, Adam Taich, 10x Genomics, TXG, CFO